Global Paradise System US Post Approval Study (US GPS)
The Global Paradise® System US Post Approval Study (US GPS)
Sponsor: ReCor Medical, Inc.
This observational or N/A phase trial investigates Cardiovascular Diseases and Hypertension and is currently actively recruiting participants. ReCor Medical, Inc. leads this study, which shows 14 recorded versions since 2024 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
14 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Nov 2025 — Feb 2026 [monthly]
Recruiting
-
Oct 2025 — Nov 2025 [monthly]
Recruiting
-
Aug 2025 — Oct 2025 [monthly]
Recruiting
-
Jun 2025 — Aug 2025 [monthly]
Recruiting
▶ Show 9 earlier versions
-
May 2025 — Jun 2025 [monthly]
Recruiting
-
Mar 2025 — May 2025 [monthly]
Recruiting
-
Dec 2024 — Mar 2025 [monthly]
Recruiting
-
Nov 2024 — Dec 2024 [monthly]
Recruiting
-
Oct 2024 — Nov 2024 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ReCor Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .